StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) shareholders

SAENNasdaqBiological Products, (No Diagnostic Substances)
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58−0.02 (-3.83%)

Close on Nov 17, 2026Market cap $13.52MP/E –Yield –

Ownership

Who owns Genenta Science S.p.A.'s shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Marco Nuzzo
Joint filing with Luigi Naldini (11.50%), Bernhard Gentner (11.50%) and 8 more
5,543,91011.50%13D (active) amendmentMay 29, 2026
Pierluigi Paracchi2,302,5169.80%13G (passive) amendmentJan 25, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Pierluigi ParacchiChief Executive Officer, Director, 10% owner27,0000.12%May 5, 2026
Francesco GalimiCMO& Head of Development, Director0–Apr 1, 2026
Richard B. SlanskyChief Financial Officer2,2000.01%Apr 1, 2026
Giacomoantonio ParacchiDirector0–Apr 1, 2026
Armon ShareiDirector0–Apr 1, 2026
Miguel Maria MuttiDirector0–Apr 1, 2026

See a number that looks wrong?